313 |
English |
Tuberculosis |
Depreciated |
Link |
Tonmoy |
Abhimanyu |
2 years 10 months |
367 |
English |
Planning, PIP and Finance Management |
Under Development |
|
Namrata |
PrashantBhat |
2 years 10 months |
383 |
English |
TB Case Finding |
Under Development |
Link |
Namrata |
PrashantBhat |
2 years 10 months |
381 |
English |
Norms and requirements of a DMC |
Page Prioritised |
Link |
Namrata |
ShikhaDhawan |
2 years 10 months |
398 |
English |
CBNAAT Xpert MTB/RIF Assay/Cartridge |
Page Prioritised |
Link |
Namrata |
ShikhaDhawan |
2 years 10 months |
458 |
English |
CBNAAT Xpert MTB/RIF - Indications of use under NTEP |
Page Prioritised |
Link |
Namrata |
ShikhaDhawan |
2 years 10 months |
494 |
English |
Request for TB tests |
Page Prioritised |
|
Namrata |
ShikhaDhawan |
2 years 9 months |
482 |
English |
Second Line LPA [SLLPA] |
Page Prioritised |
|
Namrata |
ShikhaDhawan |
2 years 9 months |
888 |
English |
Managerial Skills |
Page Prioritised |
|
Namrata |
Abhimanyu |
2 years 8 months |
655 |
English |
Patient Support |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1006 |
English |
Management of DR-TB ADR: Depression |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1008 |
English |
Management of DR-TB ADR: Suicidal Ideation |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1009 |
English |
Management of DR-TB ADR: Seizures |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1011 |
English |
Management of DR-TB ADR: Gynecomastia |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1032 |
English |
Delamanid [Dlm] Drug Dosages and Duration |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1126 |
English |
Newer Anti-TB Drugs: Bedaquiline [Bdq] |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1128 |
English |
Newer Anti-TB Drugs: Delamanid [Dlm] |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1133 |
English |
Prevention of Drug-resistance |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1162 |
English |
Quality Assurance of Anti-TB Drugs |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1163 |
English |
Universal Access to Quality TB Care |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1164 |
English |
End TB Strategy Approach |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1165 |
English |
Functions of District National Health Mission |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1167 |
English |
Roles of Accredited Social Health Activist [ASHA] for TB Service Delivery at ABHWCs |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1168 |
English |
Recording and Reporting at Ayushman Bharat Health and Wellness Centres |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1170 |
English |
Importance of Properly Identifying Presumptive TB Cases |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1172 |
English |
Precautions to Ensure Reliability of a Test for Diagnosis of DR-TB |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1184 |
English |
TB Control Program SWOT Analysis |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1188 |
English |
NTEP Tuberculosis Unit Drug Store |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1190 |
English |
Drugs, Consumables and Financial Support at Ayushman Bharat Health and Wellness Centres |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1199 |
English |
Vulnerable Population Mapping for TB Screening |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1203 |
English |
Strategic TB Screening Interventions for the key populations |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1204 |
English |
TB Screening: Children Younger than 10 Years |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1207 |
English |
Laboratory Technicians: Terms of Reference [TORs] at the Intermediate Reference Laboratory |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1216 |
English |
Criteria for Acceptance and Rejection of TB Specimens at TB Diagnostic Laboratories |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1217 |
English |
Precautions to be Undertaken for TB Diagnostic Specimen Collection, Transport and Receipt |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1223 |
English |
Purpose of Acid Fast Bacilli [AFB] Microscopy under NTEP |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1224 |
English |
Smear Microscopic Examination: Different Grades of Smear Findings |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1226 |
English |
Prevention of False Positive Results During Smear Microscopy |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1227 |
English |
Prevention of False Negative Results During Smear Microscopy |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1231 |
English |
State Programmatic Management of Drug-resistant TB [PMDT] Committee |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1382 |
English |
Provisions under the NTEP for the Nodal DR-TB Centre |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1389 |
English |
Palliative Care: Need for Human Resource and Infrastructure |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1392 |
English |
Safety Precautions to be Followed in TB Laboratory Setting |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1393 |
English |
Sputum Smear Preparation: Selecting the Best Portion of the Sputum Specimen for Microscopy |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1395 |
English |
Sputum Smear Microscopy: Recording Results for Reagent Validation at the TB Laboratory |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1398 |
English |
External Quality Assurance [EQA] for Microscopy |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1399 |
English |
Intended Use of TrueNAT MTB and TrueNAT MTB Rif Dx Assay |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1402 |
English |
TrueNAT Test Sample Storage and Transportation Procedure |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1408 |
English |
Results Interpretation of Mycobacterium tuberculosis Detected-RIF Indeterminate in TrueNAT Assay |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |
1409 |
English |
Limitations of TrueNAT MTB Assay |
Page Prioritised |
|
Archana.Singh |
Abhimanyu |
2 years 8 months |